Leukoreduced PRBCs vs non‐leukoreduced PRBCs
Adverse events · Patients receiving RBC transfusion
Leukoreduced PRBCs showed no clear difference in adverse events compared with non‐leukoreduced PRBCs (low certainty).
1 finding from 1 review
- Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion 2015 · Cochrane Headline outcomes onlyRR 0.81 [0.64, 1.02]2 studies · 634 participantsLow